Showing results (41-50 of 511) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|February 13, 2023
Knowledge and Interdisciplinary Communication of Gastroenterologists and Dentists in the Netherlands About Gastrointestinal Diseases With Oral ManifestationsChristopher X W Tan, Henk S Brand, Oumaima Qaddour, et al.
Crohn'S & Colitis 360|February 13, 2023
Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study ResultsJeffrey S Hyams, Christopher D O'Brien, Lakshmi Padgett, et al.
Crohn'S & Colitis 360|February 13, 2023
Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel DiseaseAnand Kumar, Emilie S Kim, Philip Kozan, et al.
Crohn'S & Colitis 360|February 13, 2023
#MondayNightIBD: Management of Chronic #PouchitisJean A Donet, Florian Rieder, Aline Charabaty
Crohn'S & Colitis 360|February 13, 2023
Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department UtilizationEllina Lytvyak, Reed T Sutton, Levinus A Dieleman, et al.
Crohn'S & Colitis 360|February 13, 2023
Ustekinumab Successfully Treats and Maintains Remission of Pyostomatitis Vegetans Associated with Crohn's DiseaseSarah Abi Doumeth, Ossama Abbas, Jana G Hashash
Crohn'S & Colitis 360|February 13, 2023
Models of Care for Inflammatory Bowel Disease: A National Cross-sectional Survey to Characterize the Landscape of Inflammatory Bowel Disease Care in CanadaMatthew Miles, Juan Nicolás Peña-Sánchez, Courtney Heisler, et al.
Crohn'S & Colitis 360|February 13, 2023
The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020Mads Damsgaard Wewer, Laura Arp, Melek Sarikaya, et al.
Crohn'S & Colitis 360|February 13, 2023
Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel DiseaseEva M Szigethy, Sean M Murphy, Orna G Ehrlich, et al.
Crohn'S & Colitis 360|February 13, 2023
The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease PatientsNabeel Khan, Dhruvan Patel, Tyler Pernes, et al.
Pageof 52